)
Edge28 Aug 2026
Bigger, Sharper, IMAX: A Blockbuster Business
How IMAX turned an unscalable, large-screen format into the center of blockbuster filmmaking through cameras, projection, and remastering technology.
Champions Oncology
Champions Oncology (CSBR) investor relations material
Champions Oncology Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary28 Aug, 2026
Executive summary
Annual Meeting scheduled for October 14, 2026, with record date set as August 21, 2026.
Shareholders will vote on director elections, auditor ratification, executive compensation, frequency of say-on-pay votes, and a new equity incentive plan.
Proxy materials are available online, and shareholders are encouraged to vote electronically or by mail.
Voting matters and shareholder proposals
Election of seven director nominees for one-year terms.
Ratification of EisnerAmper LLP as independent auditor for fiscal year ending April 30, 2027.
Advisory vote on executive compensation (say-on-pay) and on the frequency of such votes, with board recommending every three years.
Approval of the 2026 Equity Incentive Plan, authorizing new equity awards.
Board of directors and corporate governance
Board consists of seven members, with five deemed independent under Nasdaq rules.
Recent leadership changes: Robert Brainin became CEO in August 2025; Ronnie Morris transitioned to Chairman.
Board met three times in fiscal 2026; all directors attended at least 75% of meetings.
Committees include Audit, Compensation, and Nominating & Corporate Governance, all with independent members.
Shareholders can communicate with the board via written correspondence.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Champions Oncology
- Annual meeting to vote on directors, auditor, executive pay, and equity plan.CSBR
Proxy filing - Record revenue and positive adjusted EBITDA achieved, with core services growth and margin gains.CSBRQ4 2026
- Record study service revenue and positive adjusted EBITDA, with margin improvement expected.CSBRQ3 2026
- Quarterly revenue up 11–11.5% to $15M, margin at 52%, and adjusted EBITDA near $843K.CSBRQ2 2026
- Q1 revenue was $14.0M, with margin pressure, net loss, and positive cash flow from operations.CSBRQ1 2026
- Q2 revenue up 17% to $13.5M, with margin gains and new data licensing amid liquidity risks.CSBRQ2 2025
- Revenue up 12% and return to profitability, but liquidity and going concern risks remain.CSBRQ1 2025
- Q4 revenue up 7% and adjusted EBITDA positive, signaling improved outlook.CSBRQ4 2024
- Record revenue and net income driven by data licensing and operational efficiency.CSBRQ3 2025
Next Champions Oncology earnings date
Q1 202710 Sep, 2026
Champions Oncology
Next Champions Oncology earnings date
Q1 202710 Sep, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage